53. Aun CS, Short SM, Leung DH, Oh TE: Induction
dose-response of propofol in unpremedicated chil-
dren. Br J Anaesth 68:64–67, 1992.
54. Smith C, McEwan A, Jhaveri R: Reduction of propo-
fol Cp50 by fentanyl. Anesthesiology 77:A340, 1992.
55. Mackenzie N, Grant IS: Propofol for intravenous
sedation. Anaesthesia 42:3–6, 1987.
56. Wilson E, Mackenzie N, Grant IS: A comparison of
propofol and midazolam by infusion to provide
sedation in patients who receive spinal anaesthesia.
Anaesthesia 43(Suppl):91–94, 1988.
57. Veselis RA, Reinsel RA, Wronski M, et al: EEG and
memory effects of low-dose infusions of propofol.
Br J Anaesth 69:246–254, 1992.
58. Zacny JP, Lichtor JL, Coalson DW, et al: Subjective
and psychomotor effects of subanesthetic doses of
propofol in healthy volunteers. Anesthesiology
76:696–702, 1992.
59. Kelly JS, Roy RC: Intraoperative awareness with
propofol-oxygen total intravenous anesthesia for
microlaryngeal surgery. Anesthesiology 77:207–
209, 1992.
60. McDonald NJ, Mannion D, Lee P, et al: Mood eva-
luation and outpatient anaesthesia: A comparison
between propofol and thiopentone. Anaesthesia
43(Suppl)68–69, 1988.
61. Nelson V: Hallucinations after propofol. Anaesthe-
sia 43:170, 1988.
62. Cameron A: Opisthotonos again. Anaesthesia
42:1124, 1987.
63. Hazeau C, Tisserant D, Vespignani H: Electroen-
cephalographic changes produced by propofol.Ann
Fr Anesth Reanim 6:261, 1987.
64. Yate PM, Maynard DE, Major E, et al: Anaesthesia
with ICI 35,868 monitored by the cerebral function
analysing monitor (CFAM). Eur J Anaesthesiol
3:159–166, 1986.
65. Glass PS, Bloom M, Kearse L, et al: Bispectral analy-
sis measures sedation and memory effects of propo-
fol, midazolam, isoflurane, and alfentanil in healthy
volunteers. Anesthesiology 86:836–847, 1997.
66. Maurette P, Simeon F, Castagnera L, et al: Propofol
anaesthesia alters somatosensory evoked cortical
potentials. Anaesthesia 43(Suppl):44–45, 1988.
67. Savoia G, Esposito C, Belfiore F, et al: Propofol infu-
sion and auditory evoked potentials. Anaesthesia
43(Suppl)46–49, 1988.
68. Vanluchene AL, Vereecke H, Thas O, et al: Spectral
entropy as an electroencephalographic measure of
anesthetic drug effect: A comparison with bispec-
tral index and processed midlatency auditory
evoked response. Anesthesiology 101:34–42, 2004.
69. al-Hader A, Hasan M, Hasan Z: The comparative
effects of propofol, thiopental, and diazepam, admi-
nistered intravenously, on pentylenetetrazol seizure
threshold in the rabbit. Life Sci 51:779–786, 1992.
70. Heavner J, Arthur J, Zou J: Propofol vs. thiopental
for treating bupivacaine induced seizures in rats.
Anesthesiology 77:A802, 1992.
71. Chilvers CR, Laurie PS: Successful use of propofol in
status epilepticus. Anaesthesia 45:995–996, 1990.
72. Dwyer R, McCaughey W, Lavery J, et al: Compari-
son of propofol and methohexitone as anaesthetic
agents for electroconvulsive therapy. Anaesthesia
43:459–462, 1988.
73. Hodkinson BP,Frith RW,Mee EW: Propofol and the
electroencephalogram. Lancet 2:1518, 1987.
74. Committee on Safety of Medicines.: Propofol. Curr
Probl:20, 1987.
75. Keidan I, Perel A, Shabtai EL, Pfeffer RM: Children
undergoing repeated exposures for radiation
therapy do not develop tolerance to propofol: Cli-
nical and bispectral index data. Anesthesiology
100:251–254, 2004.
76. Cohen Y, Feldinger E, Ogorek D, Weinbroum AA:
Increased propofol requirement during succeeding
administrations for electroconvulsive therapy. J
Clin Anesth 16:282–285, 2004.
77. Follette JW, Farley WJ: Anesthesiologist addicted to
propofol. Anesthesiology 77:817–818, 1992.
78. Mendes PM, Silberstein SD, Young WB, et al: Intra-
venous propofol in the treatment of refractory hea-
dache. Headache 42:638–641, 2002.
79. Vandesteene A, Trempont V, Engelman E, et al:
Effect of propofol on cerebral blood flow and meta-
bolism in man. Anaesthesia 43(Suppl):42–43, 1988.
80. Steiner LA, Johnston AJ, Chatfield DA, et al: The
effects of large-dose propofol on cerebrovascular
pressure autoregulation in head-injured patients.
Anesth Analg 97:572–576, 2003.
81. Mirakhur RK, Shepherd WF, Darrah WC: Propofol
or thiopentone: Effects on intraocular pressure
associated with induction of anaesthesia and tra-
cheal intubation (facilitated with suxamethonium).
Br J Anaesth 59:431–436, 1987.
82. Enns J, Gelb A, Manninen P: Cerebral autoregula-
tion is maintained during propofol-nitrous oxide
anaesthesia in humans. Can J Anaesth 39:A43,
1992.
83. Kochs E, Hoffman WE, Werner C, et al: The effects
of propofol on brain electrical activity, neurologic
outcome, and neuronal damage following incom-
plete ischemia in rats. Anesthesiology 76:245–252,
1992.
84. Gelb AW, Bayona NA, Wilson JX, Cechetto DF:
Propofol anesthesia compared to awake reduces
infarct size in rats. Anesthesiology 96:1183–1190,
2002.
85. Bhardwaj A, Castro IA,Alkayed NJ, et al: Anesthetic
choice of halothane versus propofol: Impact on
experimental perioperative stroke. Stroke 32:1920–
1925, 2001.
86. Kaptanoglu E, Sen S, Beskonakli E, et al: Antioxi-
dant actions and early ultrastructural findings of
thiopental and propofol in experimental spinal cord
injury. J Neurosurg Anesthesiol 14:114–122, 2002.
87. Amorim P,Chambers G,Cottrell J,Kass IS: Propofol
reduces neuronal transmission damage and atte-
nuates the changes in calcium, potassium, and
sodium during hyperthermic anoxia in the rat
hippocampal slice. Anesthesiology 83:1254–1265,
1995.
88. Ergun R, Adkemir G, Sen S, et al: Neuroprotective
effects of propofol following global cerebral ische-
mia in rats. Neurosurg Rev, 2001.
89. Kawaguchi M,Furuya H,Patel PM: Neuroprotective
effects of anesthetic agents. J Anesth 19:150–156,
2005.
90. Lanigan C, Sury M, Bingham R, et al: Neurological
sequelae in children after prolonged propofol infu-
sion. Anaesthesia 47:810–811, 1992.
91. Vuyk J, Engbers FH, Lemmens HJ, et al: Pharmaco-
dynamics of propofol in female patients. Anesthe-
siology 77:3–9, 1992.
92. Forrest FC, Tooley MA, Saunders PR, Prys-Roberts
C: Propofol infusion and the suppression of cons-
ciousness: The EEG and dose requirements. Br J
Anaesth 72:35–41, 1994.
93. Spelina KR, Coates DP, Monk CR, et al: Dose requi-
rements of propofol by infusion during nitrous
oxide anaesthesia in man. I: Patients premedicated
with morphine sulphate. Br J Anaesth 58:1080–
1084, 1986.
94. Kazama T, Ikeda K, Morita K, Sanjo Y: Awakening
propofol concentration with and without blood-
effect site equilibration after short-term and long-
term administration of propofol and fentanyl
anesthesia. Anesthesiology 88:928–934, 1998.
95. Sanderson JH, Blades JF: Multicentre study of pro-
pofol in day case surgery.Anaesthesia 43(Suppl):70–
73, 1988.
96. Taylor MB, Grounds RM, Mulrooney PD, Morgan
M: Ventilatory effects of propofol during induction
of anaesthesia: Comparison with thiopentone.
Anaesthesia 41:816–820, 1986.
97. Goodman NW, Black AM, Carter JA: Some venti-
latory effects of propofol as sole anaesthetic agent.
Br J Anaesth 59:1497–1503, 1987.
98. Gold MI, Abraham EC, Herrington C: A controlled
investigation of propofol, thiopentone and metho-
hexitone. Can J Anaesth 34:478–483, 1987.
99. Jonsson MM, Lindahl SG, Eriksson LI: Effect of
propofol on carotid body chemosensitivity and
cholinergic chemotransduction.Anesthesiology 102:
110–116, 2005.
100. Conti G,Dell’Utri D,VilardiV,et al: Propofol induces
bronchodilation in mechanically ventilated chronic
obstructive pulmonary disease (COPD) patients.
Acta Anaesthesiol Scand 37:105–109, 1993.
101. Brown RH, Wagner EM: Mechanisms of broncho-
protection by anesthetic induction agents: Propofol
versus ketamine. Anesthesiology 90:822–828, 1999.
102. Lin CC, Shyr MH, Tan PP, et al: Mechanisms
underlying the inhibitory effect of propofol on the
contraction of canine airway smooth muscle.Anes-
thesiology 91:750–759, 1999.
103. Brown RH, Greenberg RS, Wagner EM: Efficacy of
propofol to prevent bronchoconstriction: Effects of
preservative. Anesthesiology 94:851–855, 2001.
104. Basu S, Mutschler DK, Larsson AO, et al: Propofol
(Diprivan-EDTA) counteracts oxidative injury and
deterioration of the arterial oxygen tension during
experimental septic shock. Resuscitation 50:341–
348, 2001.
105. Chang H, Tsai S, Chang Y, et al: Therapeutic con-
centrations of propofol protects mouse macropha-
ges from nitric oxide-induced cell death and
apoptosis. Can J Anaesth 49:477, 2002.
106. Kondo U, Kim SO, Murray PA: Propofol selectively
attenuates endothelium-dependent pulmonary
vasodilation in chronically instrumented dogs.
Anesthesiology 93:437–446, 2000.
107. Horibe M, Ogawa K, Sohn JT, Murray PA: Propofol
attenuates acetylcholine-induced pulmonary vaso-
relaxation: Role of nitric oxide and endothelium-
derived hyperpolarizing factors. Anesthesiology
93:447–455, 2000.
108. Larsen R, Rathgeber J, Bagdahn A, et al: Effects of
propofol on cardiovascular dynamics and coronary
blood flow in geriatric patients: A comparison with
etomidate. Anaesthesia 43(Suppl):25–31, 1988.
109. Vermeyen KM, Erpels FA, Janssen LA, et al: Propo-
fol-fentanyl anaesthesia for coronary bypass surgery
in patients with good left ventricular function. Br J
Anaesth 59:1115–1120, 1987.
110. Patrick M, Blair I, Feneck R: A comparison of the
haemodynamic effects of propofol (Diprivan) and
thiopentone in patients with coronary artery
disease. Postgrad Med J 61:23, 1985.
111. Stephan H, Sonntag H, Schenk HD, et al: Effects of
propofoloncardiovasculardynamics,myocardialblood
flow and myocardial metabolism in patients with coro-
nary artery disease. Br J Anaesth 58:969–975, 1986.
112. Coates D, Prys-Roberts C, Spelina K: Propofol
(Diprivan) by intravenous infusion with nitrous
oxide: Dose requirements and hemodynamic
effects. Postgrad Med J 61:76, 1985.
113. Van Aken H, Meinshausen E, Prien T, et al: The
influence of fentanyl and tracheal intubation on the
hemodynamic effects of anesthesia induction with
propofol/N
2
O in humans. Anesthesiology 68:157–
163, 1988.
526
Farmacología y anestesia
II